PT Kalbe Farma Tbk. (PTKFF) Stock Price & Analysis
PT Kalbe Farma Tbk. (PTKFF) — price $0.04 (0.00%), as of the Nov 20, 2026 trading session; market cap $1.81B.
Educational signal · not a buy or sell recommendation · How to read this
PT Kalbe Farma Tbk. · PTKFF
PT Kalbe Farma Tbk. is an Indonesia-based pharmaceutical powerhouse operating across prescription pharmaceuticals, consumer health, nutritionals, and distribution. The company leverages its diverse product portfolio and extensive domestic network to serve a broad range of healthcare needs.
Price as of Nov 20, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.04 | |
| Change on the day | 0.00% | |
| Market capitalisation | $1.81B | — |
| Price / earnings (trailing) | 9.37 | |
| Shares traded on the day | 10.0K |
Price & events
Other perspectives
Council score for PT Kalbe Farma Tbk. (PTKFF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 2, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 29, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 22, 2026, except a card that shows its own read date.
What is PT Kalbe Farma Tbk. (PTKFF), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. PT Kalbe Farma Tbk. (PTKFF) is the company analyzed here. It employs 12,726 people. In Q3 FY2026 it reported revenue of IDR 9480.78B and net income of IDR 816.19B. The market values it at $1.81B.
What do the latest results show for PT Kalbe Farma Tbk. (PTKFF)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of IDR 9480.78B. Against analyst estimates the company has EPS beat 3 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | IDR 9480.78B | IDR 816.19B | IDR 17.83 (diluted) |
| Q2 FY2026 | IDR 9870.62B | IDR 896.91B | IDR 19.78 (diluted) |
| Q1 FY2026 | IDR 9700.54B | IDR 1031.29B | IDR 22.74 (diluted) |
| Q4 FY2025 | IDR 9336.25B | IDR 1033.65B | IDR 22.71 (diluted) |
What are the financial strengths and risks for PT Kalbe Farma Tbk. (PTKFF)?
Short answer · as of
The distress and quality screens read Altman Z 6.18 · Piotroski F 6. Trailing ratios: ROE 15.2% · ROA 10.9% · current ratio 3.15 · earnings yield 11.0% · free-cash-flow yield 7.5%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held PTKFF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported PTKFF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What Investors Ask About PT Kalbe Farma Tbk. (PTKFF)
These answers are editorial: 1 of these 8 answers is drawn from the PTKFF research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is PTKFF a good stock to buy?
Stock Expert AI does not rate PTKFF buy, sell or hold. PT Kalbe Farma Tbk. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the PTKFF stock price today?
The last price recorded for PT Kalbe Farma Tbk. (PTKFF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks associated with investing in PTKFF?
carries several notable risks. A primary concern stems from its classification as an OTC Other stock, which inherently involves less stringent listing requirements, potential liquidity issues, and an "Unknown" disclosure status, making comprehensive due diligence challenging.
What are the key factors to evaluate for PTKFF?
Evaluate PTKFF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Expansion of Nutritional Product Portfolio: PT Kalbe Farma Tbk. Not financial advice.
How frequently does PTKFF data refresh on this page?
PTKFF's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven PTKFF's recent stock price performance?
PT Kalbe Farma Tbk. (PTKFF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider PTKFF overvalued or undervalued right now?
The trailing P/E of PT Kalbe Farma Tbk. (PTKFF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research PTKFF before investing?
(PTKFF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 9 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com